Exciting Time, Data Center Construction Booming: Aon CFO
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
13 minutes ago
- Bloomberg
UBS Settles Credit Suisse Mortgage-Bond Case for $300 Million
UBS Group AG said it has reached an agreement with the US Department of Justice to resolve a legacy Credit Suisse matter related to the former bank's role in selling residential mortgage-backed securities in the US. 'On 1 August 2025, Credit Suisse Securities (USA) LLC entered into an agreement with the DOJ to resolve all of Credit Suisse's outstanding Consumer Relief Obligations under the 2017 settlement by paying $300 million,' the bank said in a statement on Monday.
Yahoo
33 minutes ago
- Yahoo
The Rise of Social Investing: Why Following Experts Might Be Your Best Move
Sometimes, your best investment move might be watching someone else make theirs. That's the idea behind a fast-growing trend known as social investing, a model that's becoming increasingly mainstream thanks to platforms like eToro and X accounts like Pelosi Tracker, which has amassed a following by tracking the trades of high-profile politicians and public figures. The big appeal? You don't need to be a market genius to make smarter moves; you can simply follow people who are. Don't Miss: $100k+ in investable assets? – no cost, no obligation. Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora & MGM— When Elon Musk Posts, Markets Listen A 2023 peer-reviewed study in the Technological Forecasting and Social Change journal dug into the so-called Musk Effect. It examined 47 cryptocurrency-related posts by Tesla (NASDAQ:TSLA) CEO Elon Musk and found that even a single X post could result in abnormal returns of up to 4.79% within an hour, along with surging trading volumes. In the first two minutes, the abnormal returns were 3.58%. The researchers wrote that Musk's posts often blur the line between jokes and market-moving statements. One famous example? In 2021, he simply changed his X bio to '#bitcoin,' causing the price to jump from $32,000 to over $38,000 in just a few hours. That single act added $111 billion to Bitcoin's market cap. This brings up questions about whether that's fair or safe for everyday investors, but it also makes something very clear: big personalities online can really move the markets, and more and more people are paying attention. Trending: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can Social Investing Puts You In The Room With Experts The idea behind social investing is simple: if a seasoned investor or market mover is making a move, and you have access to that information, why not ride the same wave? That's exactly what eToro (NASDAQ:ETOR) has built its platform around. With eToro's CopyTrader feature, you can view and automatically replicate the portfolios of top investors, including those with long-term track records of success, with as little as $200. Whether you're into crypto, stocks, or ETFs, you can browse real-world returns and match your strategy to theirs with just a click. It's investing, but social, transparent and tailored to match your goals. Investing In The Age Of Digital Overload It's no secret that markets move fast, especially when social media accelerates the news cycle. But this constant flood of noise is exactly why some investors are choosing curated, signal-driven strategies instead of relying on gut study on Musk's social media influence pointed to a broader issue: investors struggle with information overload. Too many headlines, too many conflicting opinions, and too little time to sift through it all. That's what makes social investing appealing: it filters the noise by giving you real-time access to what skilled traders are actually doing, not just saying. Watch What They Do And Act Accordingly Social trading doesn't guarantee returns, but it offers a level of transparency that traditional finance often lacks. With tools like Pelosi Tracker, investors are watching lawmakers' trades for signs of market conviction. And with eToro, you're not just watching, you're participating. When one social media post can send markets soaring or crashing, just keeping up with the news isn't enough. You're better off following the people who are already making big moves. Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? TESLA (TSLA): Free Stock Analysis Report This article The Rise of Social Investing: Why Following Experts Might Be Your Best Move originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
an hour ago
- Yahoo
Pfizer (PFE) Reports Earnings Tomorrow: What To Expect
Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here's what to look for. Pfizer missed analysts' revenue expectations by 1.6% last quarter, reporting revenues of $13.72 billion, down 7.8% year on year. It was a mixed quarter for the company, with a solid beat of analysts' organic revenue estimates but a miss of analysts' full-year EPS guidance estimates. Is Pfizer a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Pfizer's revenue to grow 2.2% year on year to $13.58 billion, in line with the 2.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.57 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 6 downward revisions over the last 30 days (we track 11 analysts). Pfizer has missed Wall Street's revenue estimates three times over the last two years. Looking at Pfizer's peers in the branded pharmaceuticals segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Bristol-Myers Squibb posted flat year-on-year revenue, beating analysts' expectations by 7.8%, and Merck reported a revenue decline of 1.9%, falling short of estimates by 1.1%. Bristol-Myers Squibb traded down 3.9% following the results while Merck was also down 2.7%. Read our full analysis of Bristol-Myers Squibb's results here and Merck's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the branded pharmaceuticals stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.3% on average over the last month. Pfizer is down 6.8% during the same time and is heading into earnings with an average analyst price target of $28.67 (compared to the current share price of $23.53). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
